Nagel S - Search Results

1

RBFOX2 and alternative splicing in B-cell lymphoma.

Quentmeier H, Pommerenke C, Bernhart SH, Dirks WG, Hauer V, Hoffmann S, Nagel S, Siebert R, Uphoff CC, Zaborski M, Drexler HG; ICGC MMML-Seq Consortium. Quentmeier H, et al. Among authors: nagel s. Blood Cancer J. 2018 Aug 10;8(8):77. doi: 10.1038/s41408-018-0114-3. Blood Cancer J. 2018. PMID: 30097561 Free PMC article. No abstract available.

2

Multicolor-FISH analysis of a natural killer cell line (NK-92).

MacLeod RA, Nagel S, Kaufmann M, Greulich-Bode K, Drexler HG. MacLeod RA, et al. Among authors: nagel s. Leuk Res. 2002 Nov;26(11):1027-33. doi: 10.1016/s0145-2126(02)00055-3. Leuk Res. 2002. PMID: 12363472

3

Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).

MacLeod RA, Nagel S, Kaufmann M, Janssen JW, Drexler HG. MacLeod RA, et al. Among authors: nagel s. Genes Chromosomes Cancer. 2003 May;37(1):84-91. doi: 10.1002/gcc.10194. Genes Chromosomes Cancer. 2003. PMID: 12661009

4

The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2).

Nagel S, Kaufmann M, Drexler HG, MacLeod RA. Nagel S, et al. Cancer Res. 2003 Sep 1;63(17):5329-34. Cancer Res. 2003. PMID: 14500364

5

BCL11B rearrangements probably target T-cell neoplasia rather than acute myelocytic leukemia.

MacLeod RA, Nagel S, Drexler HG. MacLeod RA, et al. Among authors: nagel s. Cancer Genet Cytogenet. 2004 Aug;153(1):88-9. doi: 10.1016/j.cancergencyto.2004.02.020. Cancer Genet Cytogenet. 2004. PMID: 15325104 No abstract available.

6

Activation of HLXB9 by juxtaposition with MYB via formation of t(6;7)(q23;q36) in an AML-M4 cell line (GDM-1).

Nagel S, Kaufmann M, Scherr M, Drexler HG, MacLeod RA. Nagel S, et al. Genes Chromosomes Cancer. 2005 Feb;42(2):170-8. doi: 10.1002/gcc.20113. Genes Chromosomes Cancer. 2005. PMID: 15540222

7

HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3.

Nagel S, Scherr M, Quentmeier H, Kaufmann M, Zaborski M, Drexler HG, MacLeod RA. Nagel S, et al. Leukemia. 2005 May;19(5):841-6. doi: 10.1038/sj.leu.2403716. Leukemia. 2005. PMID: 15772702

8

Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1.

Nagel S, Burek C, Venturini L, Scherr M, Quentmeier H, Meyer C, Rosenwald A, Drexler HG, MacLeod RA. Nagel S, et al. Blood. 2007 Apr 1;109(7):3015-23. doi: 10.1182/blood-2006-08-044347. Blood. 2007. PMID: 17148583 Free article.

9

Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.

Nagel S, Scherr M, Kel A, Hornischer K, Crawford GE, Kaufmann M, Meyer C, Drexler HG, MacLeod RA. Nagel S, et al. Cancer Res. 2007 Feb 15;67(4):1461-71. doi: 10.1158/0008-5472.CAN-06-2615. Cancer Res. 2007. PMID: 17308084

10

Amplification at 7q22 targets cyclin-dependent kinase 6 in T-cell lymphoma.

Nagel S, Leich E, Quentmeier H, Meyer C, Kaufmann M, Drexler HG, Zettl A, Rosenwald A, MacLeod RA. Nagel S, et al. Leukemia. 2008 Feb;22(2):387-92. doi: 10.1038/sj.leu.2405028. Epub 2007 Nov 8. Leukemia. 2008. PMID: 17989712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

884 results

Search Page